[Form 4] ALPHA PRO TECH LTD Insider Trading Activity
Dr. John Ritota, a director of Alpha Pro Tech Ltd (APT), received a grant of 5,615 time-based restricted stock units under the companys 2020 Omnibus Plan that vest in full on the first anniversary of the grant, subject to the plan and award agreement. After the reported transaction the filing shows Dr. Ritota beneficially owns 48,355 shares of APT common stock. The form also reports indirect holdings of 5,000 shares held by his daughter and 7,000 shares held by his spouse, which Dr. Ritota disclaims beneficial ownership of. This disclosure reflects a routine equity award to a director and the current direct and indirect ownership positions reported on the Form 4.
Il dottor John Ritota, direttore di Alpha Pro Tech Ltd (APT), ha ricevuto un assegnamento di 5.615 unità azionarie vincolate nel tempo (restricted stock units) ai sensi del piano Omnibus 2020 della società, che maturano integralmente al primo anniversario della data di conferimento, soggetto al piano e all’accordo di assegnazione. Dopo la transazione riportata, la dichiarazione indica che il dottor Ritota detiene favorevolmente 48.355 azioni ordinarie di APT. Il modulo riporta inoltre posizioni indirette di 5.000 azioni detenute dalla figlia e 7.000 azioni detenute dal coniuge, che Ritota dichiara di non possedere beneficial ownership. Questa divulgazione riflette una normale assegnazione azionaria a un direttore e le attuali posizioni di proprietà diretta e indiretta riportate nel modulo 4.
El Dr. John Ritota, director de Alpha Pro Tech Ltd (APT), recibió una asignación de 5.615 unidades de acciones restringidas con base en el tiempo (RSU) conforme al plan Omnibus 2020 de la empresa, que vestirse por completo al primer aniversario de la concesión, sujeto al plan y al acuerdo de adjudicación. Tras la operación reportada, la presentación indica que el Dr. Ritota posee beneficiosamente 48.355 acciones comunes de APT. El formulario también reporta participaciones indirectas de 5.000 acciones en poder de su hija y 7.000 acciones en poder de su cónyuge, de las cuales el Dr. Ritota niega la titularidad beneficiosa. Esta divulgación refleja una asignación de acciones rutinaria a un director y las posiciones actuales de propiedad directas e indirectas reportadas en el Formulario 4.
알파 프로 테크 Ltd(APT)의 이사인 Dr. John Ritota는 회사의 2020년 Omnibus 계획하에 행사 시점에 완전히 비양도 가능한 시간 기반 제한 주식 단위(RSU) 5,615주를 받았으며, 이는 수여일로부터 1주년째에 완전히 vesting됩니다. 이는 계획 및 수여 계약의 조건에 따릅니다. 보고된 거래 후 제출 자료에 따르면 Ritota 박사는 APT 보통주 48,355주를 실질적으로 보유합니다. 또한 양식은 그의 딸이 보유한 5,000주와 배우자가 보유한 7,000주를 간접 보유하고 있음을 보고하며, Ritota는 이들 주식에 대한 유익한 소유권을 부인합니다. 이 공시는 이사에게 일반적으로 주어지는 주식 보상과 현재의 직접 및 간접 소유 포지션이 Form 4에 보고된 것을 반영합니다.
Le Dr John Ritota, administrateur d’Alpha Pro Tech Ltd (APT), a reçu une attribution de 5 615 unités d’actions restreintes basées sur le temps (RSU) dans le cadre du plan Omnibus 2020 de la société, qui vestent intégralement au premier anniversaire de la concession, sous réserve du plan et de l’accord d’attribution. Après la transaction reportée, le dossier indique que le Dr Ritota détient bénéficiellement 48 355 actions ordinaires d’APT. Le formulaire rapporte également des positions indirectes de 5 000 actions détenues par sa fille et 7 000 actions détenues par son conjoint, dont le Dr Ritota déclare ne pas être le bénéficiaire effectif. Cette divulgation reflète une attribution d’actions routinière à un administrateur et les positions actuelles de propriété directe et indirecte déclarées dans le Formulaire 4.
Dr. John Ritota, Director von Alpha Pro Tech Ltd (APT), erhielt eine Zuteilung von 5.615 zeitbasierenden Restricted Stock Units (RSUs) gemäß dem unternehmensweiten Omnibus-Plan 2020, die am ersten Jahrestag der Gewährung vollständig vesten, vorbehaltlich des Plans und der Vergütungsvereinbarung. Nach der berichteten Transaktion zeigt die Einreichung, dass Dr. Ritota rechtsverbindlich 48.355 Stammaktien von APT besitzt. Das Formular meldet zudem indirekte Beteiligungen von 5.000 Aktien, die von seiner Tochter gehalten werden, und 7.000 Aktien, die von seinem Ehepartner gehalten werden, wobei Dr. Ritota erklärt, kein wirtschaftliches Eigentum daran zu haben. Diese Offenlegung spiegelt eine routinemäßige Aktieneinzelvergütung für einen Direktor wider und die aktuellen direkten und indirekten Eigentumspositionen, die im Formular 4 gemeldet sind.
الدكتور جون ريتوتا، مدير شركة Alpha Pro Tech Ltd (APT)، تلقى منحة تبلغ 5,615 وحدة أسهم مقيدة زمنياً (RSU) وفقاً لخطة أومنيبوس 2020 للشركة، والتي تكتسب بالكامل التصديق في الذكرى السنوية الأولى للمنحة، مع مراعاة الخطة واتفاقية المنح. بعد المعاملة المذكورة، يظهر في الإبلاغ أن الدكتور ريتوتا يمتلك بشكل مفيد 48,355 سهماً من أسهم APT العادية. كما يورد النموذج ملكيات غير مباشرة من 5,000 سهم تمتلكها ابنته و7,000 سهم يمتلكها زوجها، وهي أمور ينفي ريتوتا ملكيته المفيدة لها. تعكس هذه الإفصاحية منحة أسهم روتينية لمدير والوضعيات الحالية للملكية المباشرة وغير المباشرة كما وردت في النموذج 4.
Dr. John Ritota，Alpha Pro Tech Ltd（APT）董事，根据公司2020年Omnibus计划获得了5,615单位基于时间的受限股票单位（RSU）的授予，该授予在授予后的第一周年全额归属，须符合计划及授予协议的规定。 经披露交易后，申报显示Ritota博士实际持有APT普通股48,355股。表格还报告了其女儿持有的5,000股以及其配偶持有的7,000股的间接持股，Ritota博士对这些并无受益所有权。这一披露反映了对董事的常规股票奖励，以及在Form 4中报告的直接及间接所有权现状。
- Director equity grant aligns interests The 5,615 time-based restricted stock units vesting in one year tie the directors compensation to shareholder value.
- None.
Insights
TL;DR: Routine director equity award that aligns management and shareholders; no governance red flags in the disclosure.
The Form 4 discloses a time-based restricted stock unit grant that vests in one year, which is a common mechanism to align a directors interests with long-term shareholder value. The reporting person is identified as a director and reports both direct and disclaimed indirect holdings, consistent with standard disclosure practices. There is no indication of related-party transactions beyond customary family-held shares for which the director disclaims beneficial ownership. Overall, this filing is standard governance disclosure without material control changes or unusual terms disclosed.
TL;DR: Minor insider award; unlikely to move market or materially affect share count.
The award of 5,615 restricted stock units is modest relative to typical public-company floats and will only vest subject to the plan terms, implying limited immediate dilution or selling pressure. The report shows total direct beneficial ownership of 48,355 shares after the grant, with additional family-held shares disclaimed. From a securities perspective this is a routine disclosure of compensation-related equity and personal holdings, not a significant signal of corporate strategy or financial stress.
Il dottor John Ritota, direttore di Alpha Pro Tech Ltd (APT), ha ricevuto un assegnamento di 5.615 unità azionarie vincolate nel tempo (restricted stock units) ai sensi del piano Omnibus 2020 della società, che maturano integralmente al primo anniversario della data di conferimento, soggetto al piano e all’accordo di assegnazione. Dopo la transazione riportata, la dichiarazione indica che il dottor Ritota detiene favorevolmente 48.355 azioni ordinarie di APT. Il modulo riporta inoltre posizioni indirette di 5.000 azioni detenute dalla figlia e 7.000 azioni detenute dal coniuge, che Ritota dichiara di non possedere beneficial ownership. Questa divulgazione riflette una normale assegnazione azionaria a un direttore e le attuali posizioni di proprietà diretta e indiretta riportate nel modulo 4.
El Dr. John Ritota, director de Alpha Pro Tech Ltd (APT), recibió una asignación de 5.615 unidades de acciones restringidas con base en el tiempo (RSU) conforme al plan Omnibus 2020 de la empresa, que vestirse por completo al primer aniversario de la concesión, sujeto al plan y al acuerdo de adjudicación. Tras la operación reportada, la presentación indica que el Dr. Ritota posee beneficiosamente 48.355 acciones comunes de APT. El formulario también reporta participaciones indirectas de 5.000 acciones en poder de su hija y 7.000 acciones en poder de su cónyuge, de las cuales el Dr. Ritota niega la titularidad beneficiosa. Esta divulgación refleja una asignación de acciones rutinaria a un director y las posiciones actuales de propiedad directas e indirectas reportadas en el Formulario 4.
알파 프로 테크 Ltd(APT)의 이사인 Dr. John Ritota는 회사의 2020년 Omnibus 계획하에 행사 시점에 완전히 비양도 가능한 시간 기반 제한 주식 단위(RSU) 5,615주를 받았으며, 이는 수여일로부터 1주년째에 완전히 vesting됩니다. 이는 계획 및 수여 계약의 조건에 따릅니다. 보고된 거래 후 제출 자료에 따르면 Ritota 박사는 APT 보통주 48,355주를 실질적으로 보유합니다. 또한 양식은 그의 딸이 보유한 5,000주와 배우자가 보유한 7,000주를 간접 보유하고 있음을 보고하며, Ritota는 이들 주식에 대한 유익한 소유권을 부인합니다. 이 공시는 이사에게 일반적으로 주어지는 주식 보상과 현재의 직접 및 간접 소유 포지션이 Form 4에 보고된 것을 반영합니다.
Le Dr John Ritota, administrateur d’Alpha Pro Tech Ltd (APT), a reçu une attribution de 5 615 unités d’actions restreintes basées sur le temps (RSU) dans le cadre du plan Omnibus 2020 de la société, qui vestent intégralement au premier anniversaire de la concession, sous réserve du plan et de l’accord d’attribution. Après la transaction reportée, le dossier indique que le Dr Ritota détient bénéficiellement 48 355 actions ordinaires d’APT. Le formulaire rapporte également des positions indirectes de 5 000 actions détenues par sa fille et 7 000 actions détenues par son conjoint, dont le Dr Ritota déclare ne pas être le bénéficiaire effectif. Cette divulgation reflète une attribution d’actions routinière à un administrateur et les positions actuelles de propriété directe et indirecte déclarées dans le Formulaire 4.
Dr. John Ritota, Director von Alpha Pro Tech Ltd (APT), erhielt eine Zuteilung von 5.615 zeitbasierenden Restricted Stock Units (RSUs) gemäß dem unternehmensweiten Omnibus-Plan 2020, die am ersten Jahrestag der Gewährung vollständig vesten, vorbehaltlich des Plans und der Vergütungsvereinbarung. Nach der berichteten Transaktion zeigt die Einreichung, dass Dr. Ritota rechtsverbindlich 48.355 Stammaktien von APT besitzt. Das Formular meldet zudem indirekte Beteiligungen von 5.000 Aktien, die von seiner Tochter gehalten werden, und 7.000 Aktien, die von seinem Ehepartner gehalten werden, wobei Dr. Ritota erklärt, kein wirtschaftliches Eigentum daran zu haben. Diese Offenlegung spiegelt eine routinemäßige Aktieneinzelvergütung für einen Direktor wider und die aktuellen direkten und indirekten Eigentumspositionen, die im Formular 4 gemeldet sind.
FAQ
What did APT director Dr. John Ritota receive according to the Form 4?
How many APT shares does Dr. Ritota beneficially own after the reported transaction?
Are there any indirect holdings reported by Dr. Ritota in the APT Form 4?
Do the reported transactions on the Form 4 indicate a sale or disposition of APT shares?
Are the restricted stock units immediately vested and tradeable?
